BeyondSpring Inc. Basic Shares Outstanding (Weighted Average)
BeyondSpring Inc. (BYSI) reported Basic Shares Outstanding (Weighted Average) of 41.12 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-14
- BeyondSpring Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 41.12M shares, a 1.99% increase year-over-year.
- BeyondSpring Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 41.12M shares, a 1.99% increase year-over-year.
- BeyondSpring Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 40.32M shares, a 0.04% increase year-over-year.
- BeyondSpring Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-06-30 was 40.32M shares, a 2.64% increase year-over-year.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | 41.12M shares 10-Q · filed 2026-08-14 | 41.12M shares 10-Q · filed 2026-08-14 | ||
| 2026-03-31 | 41.12M shares 10-Q · filed 2026-05-13 | |||
| 2025-09-30 | 40.32M shares 10-Q · filed 2025-11-12 | 40.32M shares derived: average of 2 quarters · filed 2026-08-14 | 40.32M shares 10-Q · filed 2025-11-12 | |
| 2025-06-30 | 40.32M shares 10-Q · filed 2026-08-14 | 40.32M shares 10-Q · filed 2026-08-14 | ||
| 2025-03-31 | 40.32M shares 10-Q · filed 2026-05-13 | |||
| 2024-09-30 | 40.30M shares 10-Q · filed 2025-11-12 | 39.79M shares derived: average of 2 quarters · filed 2025-11-12 | 39.54M shares 10-Q · filed 2025-11-12 | |
| 2024-06-30 | 39.28M shares 10-Q · filed 2025-08-13 | 39.15M shares 10-Q · filed 2025-08-13 | ||
| 2024-03-31 | 39.03M shares 10-Q · filed 2025-05-12 | |||
| 2022-12-31 | 39.09M shares 20-F · filed 2023-04-18 | |||
| 2021-12-31 | 39.02M shares 20-F · filed 2023-04-18 | |||
| 2020-12-31 | 29.98M shares 20-F · filed 2023-04-18 | |||
| 2015-12-31 | 13.91M shares 20-F · filed 2018-04-03 | |||
| 2014-12-31 | 13.91M shares 20-F · filed 2017-04-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |